After months of speculation, investors get excited about Pfizer, BioNTech’s coronavirus vaccine candidate

admin 4 years ago No Comments

This post was originally published on this site

The path to a COVID-19 vaccine has started to come into view this week, following the stock-moving disclosures of preliminary clinical data for two candidates and a rigorous new regulatory road map from the Food and Drug Administration.

Prev Article Next Article

Capitol Report: Cannabis businesses still don’t have access to banking — this congressman is trying to change that

admin April 21, 2021

: Watches of Switzerland loses a quarter of its value after Rolex deal

admin August 25, 2023

Earnings Results: Match sees Tinder subscriber growth top expectations

admin November 4, 2020

Deep Dive: The timing may be perfect for this dividend-stock fund if the market is getting close to a top

admin August 5, 2023

Need to Know: The stock market is set to fall over the next year — and is unprepared for 2 big risks, says Deutsche Bank’s wealth-management arm

admin October 21, 2020

Don’t time the market, but if you do, here’s when the bear might come knocking

admin November 29, 2019

About The Author

admin

in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

By signing up above you will receive the Daily Buzz Offers newsletter and 3rd party advertisements. Expect up to 5 messages per week from us. You can unsubscribe at any time at the bottom of any of our emails.

Related Posts

About The Author

admin